FDA Inspection 1211280 — Jeanne-Elyse G. Cedeno, M.D.

Jeanne-Elyse G. Cedeno, M.D. — FEI 3015357443

The FDA completed an inspection of Jeanne-Elyse G. Cedeno, M.D. on August 2, 2023 in Pembroke Pines, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 2, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Pembroke Pines, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
2272821 CFR 312.64(b)Safety Reports - Non-Serious Events
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance